跳至主要内容
临床试验/NCT03303391
NCT03303391终止不适用

Using Intradialytic Systolic Blood Pressure Slopes to Guide Ultrafiltration in Hemodialysis Patients: A Validation Study and Clinical Trial

University of Texas Southwestern Medical Center1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2017年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
14
试验地点
1
主要终点
Change in Mean Ambulatory Systolic Blood Pressure

研究概览

简要总结

This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintenance hemodialysis patients. It also includes a cross sectional component evaluating the associations between intradialytic blood pressure slopes ascertained over 2 week periods with measurements of extracellular water/body weight obtained with multifrequency bioimpedance spectroscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age greater than 18 years
  • •End Stage Renal Disease on Maintenance Hemodialysis
  • •Hypertension defined as systolic blood pressure > 140 mmHg pre-dialysis or >130 mmHg post dialysis

排除标准

  • •Hemodialysis Vintage < 1 month
  • •Pregnancy
  • •Nadir Systolic Blood Pressure < 95 mmHg
  • •Pre or Post dialysis systolic blood pressure > 180 mmHg
  • •Decrease in systolic blood pressure >60 mmHg from pre to post dialysis
  • •Ultrafiltration rate >13 mL/kg/hr
  • •Peridialytic Midodrine Use
  • •Intradialytic Clonidine use
  • •Documented Antihypertensive Medication Non-adherence
  • •Bioimpedance will not be peformed on patients with
  • •amputated arms or legs
  • •cardiac defibrillator or pacemaker
  • •presence of metal prostheses

研究组 & 干预措施

Standard Care

No Intervention

This arm of subjects will have all aspects of fluid management and dialysis management managed by the his/her individual nephrologist

IBPS Group

Experimental

This group will have ultrafiltration prescriptions dictated by a pre-specified protocol that is based on monthly assessment of intradialytic blood pressure slopes obtained over a two week period.

干预措施: Intradialytic Blood Pressure Slope Based Ultrafiltration (Other)

结局指标

主要结局

Change in Mean Ambulatory Systolic Blood Pressure

时间窗: Baseline, 4 months

The change in mean systolic ambulatory blood pressure from study baseline to completion (4 months)

次要结局

  • Change in Extracellular Volume/Body Weight Ratio(Baseline, 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Van Buren

Assistant Professor

University of Texas Southwestern Medical Center

研究点 (1)

Loading locations...

相似试验